Browse > Article
http://dx.doi.org/10.5230/jgc.2010.10.2.79

Mesenteric Fibromatosis Mimicking Recurrence after Distal Gastrectomy for Gastric Cancer  

Kim, Dae-Hoon (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Oh, Seung-Jong (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Oh, Jeong-A (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Bae, Young-Sik (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Choi, Min-Gew (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Noh, Jae-Hyung (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Sohn, Tae-Sung (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Kyoung-Mee (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Sung (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Bae, Jae-Moon (Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
Journal of Gastric Cancer / v.10, no.2, 2010 , pp. 79-83 More about this Journal
Abstract
Mesenteric fibromatosis is a monoclonal, fibroblastic proliferation arising from musculoaponeurotic structure, and it is distinctive lesions defined as a group of non-metastasizing fibroblastic tumors which has local invasion and has a high recurrence rate after the surgical excision. The main treatment modality is the surgical excision. Radiation therapy, chemotherapy, and hormone therapy are also known as useful treatments. We report our experience of a recent case of Mesenteric fibromatosis. A 62-year old female patient had undergone gastrectomy due to gastric cancer. 18 months after gastrectomy, we detected an abdominal mass. The preoperative radiologic findings were suggestive of recurrence. Exploratory laparotomy was performed and post-operative pathologic diagnosis was confirmed as fibromatosis. We report a patient with mesenteric fibromatosis that mimic recurrence after gastrectomy for gastric cancer.
Keywords
Fibromatosis; abdominal; Stomach neoplasms;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gega M, Yanagi H, Yoshikawa R, Noda M, Ikeuchi H, Tsukamoto K, et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 2006;24:102-105.   DOI   ScienceOn
2 Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 1990;14:335-341.   DOI   ScienceOn
3 Brooks AP, Reznek RH, Nugent K, Farmer KC, Th omson JP, Phillips RK. CT appearances of desmoid tumours in familial adenomatous polyposis. Further observations. Clin Radiol 1994;49:601-607.   DOI   ScienceOn
4 Basu S, Nair N, Banavali S. Uptake characteristics of fl uorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management. Br J Radiol 2007;80:750-756.   DOI   ScienceOn
5 Lahat G, Nachmany I, Itzkowitz E, Abu-Abeid S, Barazovsky E, Merimsky O, et al. Surgery for sporadic abdominal desmoid tumor: is low/no recurrence an achievable goal? Isr Med Assoc J 2009;11:398-402.
6 Reitamo JJ. The desmoid tumor. IV. Choice of treatment, results, and complications. Arch Surg 1983;118:1318-1322.   DOI   ScienceOn
7 Melis M, Zager JS, Sondak VK. Multimodality management of desmoid tumors: how important is a negative surgical margin? J Surg Oncol 2008;98:594-602.   DOI   ScienceOn
8 de Camargo VP, Keohan ML, D'Adamo DR, Antonescu CR, Brennan MF, Singer S, et al. Clinical outcomes of systemic therapy for patients with deep fi bromatosis (desmoid tumor). Cancer 2010;116:2258-2265.
9 Bertagnolli MM, Morgan JA, Fletcher CD, Raut CP, Dileo P, Gill RR, et al. Multimodality treatment of mesenteric desmoid tumours. Eur J Cancer 2008;44:2404-2410.
10 Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, et al. Clinical and molecular studies of the eff ect of imatinib on advanced aggressive fi bromatosis (desmoid tumor). J Clin Oncol 2006;24:1195-1203.   DOI   ScienceOn
11 Lynch HT, Fitzgibbons R Jr. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 1996;91:2598-2601.
12 Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, et al. Optimizing treatment of desmoid tumors. J Clin Oncol 2007;25:1785-1791.   DOI   ScienceOn
13 Reitamo JJ, Scheinin TM, Häyry P. Th e desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg 1986;151:230-237.   DOI   ScienceOn
14 Yannopoulos K, Stout AP. Primary solid tumors of the mesentery. Cancer 1963;16:914-927.   DOI   ScienceOn
15 Simpson RD, Harrison EG Jr, Mayo CW. Mesenteric fibromatosis in familial polyposis. A variant of Gardner's syndrome. Cancer 1964;17:526-534.   DOI   ScienceOn
16 Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as fi rst-line treatment for desmoid tumors. Cancer 2004;100:612-620.   DOI   ScienceOn
17 Pickhardt PJ, Bhalla S. Unusual nonneoplastic peritoneal and subperitoneal conditions: CT findings. Radiographics 2005;25:719-730.   DOI   ScienceOn
18 Lee JC, Thomas JM, Phillips S, Fisher C, Moskovic E. Aggressive fibromatosis: MRI features with pathologic correlation. AJR Am J Roentgenol 2006;186:247-254.   DOI   ScienceOn
19 Posner MC, Shiu MH, Newsome JL, Hajdu SI, Gaynor JJ, Brennan MF. Th e desmoid tumor. Not a benign disease. Arch Surg 1989;124:191-196.   DOI   ScienceOn
20 Lo KW. Mesenteric fi bromatosis as a potential source of falsepositive interpretation of FDG-PET: report of a case. Dis Colon Rectum 2007;50:924-926.   DOI   ScienceOn
21 Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS, Gebhardt MC, et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 1998;40:637-645.   DOI   ScienceOn
22 Reitamo JJ, Hayry P, Nykyri E, Saxen E. Th e desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the fi nnish population. Am J Clin Pathol 1982;77:665-673.   DOI
23 Allen PW. Th e fi bromatoses: a clinicopathologic classifi cation based on 140 cases. Am J Surg Pathol 1977;1:255-270.   DOI   ScienceOn
24 Dong-Heup K, Kim DH, Goldsmith HS, Quan SH, Huvos AG. Intra-abdominal desmoid tumor. Cancer 1971;27:1041- 1045.   DOI   ScienceOn